Argentum Medica

Location:MA, US
Speaker:Trevor Castor
Primary Industry:Pharma & Biotech
Executive Summary:Argentum Medica, a spin-off of Aphios Corporation, is a nanotechnology company focused on developing oral bioavailable therapeutic peptides and proteins. Aphios Corporation, based in Woburn, MA, USA, is developing enabling technology platforms for improving the discovery, manufacturing, delivery and pathogenic safety of therapeutic drugs. Argentum plans to enhance the oral bioavailability of therapeutic proteins by encapsulating protein nanoparticles in biodegradable polymer nanospheres. Nanoencapsulation will be used to protect the protein nanoparticles during the stomach passage; the residence time in the stomach will be short compared to the protein release rate from the polymer nanospheres. We have preliminary data that demonstrates that insulin, a labile peptide, being nanoencapsulated was protected in the stomach and then transported to the blood. When prodrug nanoparticles reach the gut, they can be transported across the lining, which may be mediated by M cells in the lymphatic tissue of the gut. Alternatively, the protein can be mobilized from nanoparticles and rapidly transported to systemic circulation by the epithelial cells. We believe that our oral delivery nanotechnology will be applicable to large as well small protein molecules since we have demonstrated that our protein nanoparticles technology is independent of size and molecular weight (MW).
Venture is:A-Round


Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor

University of Hawaii

Press Sponsor

Business Wire

Commercialization Partner



Invest Australia AzTE Technology Enterprises

Media Sponsors

(joint with Nanotech 2007) Nature
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network


“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
Matthew Laudon, Co-Founder and Director of TechConnect